Viveve Medical Stock Price, News & Analysis (NASDAQ:VIVE)

$4.24 -0.17 (-3.85 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$4.24
Today's Range$4.10 - $4.41
52-Week Range$3.30 - $11.16
Volume232,457 shs
Average Volume319,383 shs
Market Capitalization$132.64 million
P/E Ratio-1.96
Dividend YieldN/A
Beta-0.79

About Viveve Medical (NASDAQ:VIVE)

Viveve Medical logoViveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

Receive VIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VIVE
CUSIPN/A
Phone720-696-8100

Debt

Debt-to-Equity Ratio2.72%
Current Ratio3.89%
Quick Ratio3.63%

Price-To-Earnings

Trailing P/E Ratio-1.96296296296296
Forward P/E Ratio-2.07
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.14 million
Price / Sales18.36
Cash FlowN/A
Price / CashN/A
Book Value($0.04) per share
Price / Book-106.00

Profitability

Trailing EPS($2.16)
Net Income$-20,110,000.00
Net Margins-257.58%
Return on Equity-275.77%
Return on Assets-102.12%

Miscellaneous

Employees42
Outstanding Shares30,920,000

Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

How were Viveve Medical's earnings last quarter?

Viveve Medical Inc (NASDAQ:VIVE) posted its earnings results on Wednesday, November, 8th. The company reported ($0.50) EPS for the quarter, missing the Zacks' consensus estimate of ($0.42) by $0.08. The firm had revenue of $4.07 million for the quarter, compared to analysts' expectations of $4.10 million. Viveve Medical had a negative return on equity of 275.77% and a negative net margin of 257.58%. The firm's revenue for the quarter was up 120.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.46) earnings per share. View Viveve Medical's Earnings History.

Where is Viveve Medical's stock going? Where will Viveve Medical's stock price be in 2018?

7 brokers have issued 1-year price objectives for Viveve Medical's shares. Their predictions range from $8.00 to $11.00. On average, they expect Viveve Medical's stock price to reach $10.00 in the next twelve months. View Analyst Ratings for Viveve Medical.

Who are some of Viveve Medical's key competitors?

Who are Viveve Medical's key executives?

Viveve Medical's management team includes the folowing people:

  • James G. Atkinson, Chief Business Officer and President (Age 59)
  • Patricia K. Scheller, Chief Executive Officer, Director (Age 57)
  • Scott C. Durbin, Chief Financial Officer (Age 48)
  • Lori H. Bush, Independent Director (Age 60)
  • Daniel S. Janney, Lead Independent Director (Age 51)
  • Debora A. Jorn, Independent Director (Age 59)
  • Arlene M. Morris, Independent Director (Age 65)
  • Jon M. Plexico, Independent Director (Age 49)

When did Viveve Medical IPO?

(VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

Who owns Viveve Medical stock?

Viveve Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include RTW Investments LP (8.61%), ING Groep NV (1.80%), J. Goldman & Co LP (1.58%), MYDA Advisors LLC (0.44%) and Wells Fargo & Company MN (0.19%). Company insiders that own Viveve Medical stock include James G Atkinson, Patricia Scheller, Scott Durbin and Stonepine Capital Management,. View Institutional Ownership Trends for Viveve Medical.

Who bought Viveve Medical stock? Who is buying Viveve Medical stock?

Viveve Medical's stock was acquired by a variety of institutional investors in the last quarter, including RTW Investments LP, J. Goldman & Co LP, MYDA Advisors LLC, ING Groep NV and Wells Fargo & Company MN. Company insiders that have bought Viveve Medical stock in the last two years include James G Atkinson, Patricia Scheller, Scott Durbin and Stonepine Capital Management,. View Insider Buying and Selling for Viveve Medical.

How do I buy Viveve Medical stock?

Shares of Viveve Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Viveve Medical's stock price today?

One share of Viveve Medical stock can currently be purchased for approximately $4.24.

How big of a company is Viveve Medical?

Viveve Medical has a market capitalization of $132.64 million and generates $7.14 million in revenue each year. The company earns $-20,110,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Viveve Medical employs 42 workers across the globe.

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]


MarketBeat Community Rating for Viveve Medical (VIVE)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  105 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about Viveve Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Viveve Medical (NASDAQ:VIVE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$10.00$10.40$12.80
Price Target Upside: 172.48% upside101.21% upside116.22% upside131.88% upside

Viveve Medical (NASDAQ:VIVE) Consensus Price Target History

Price Target History for Viveve Medical (NASDAQ:VIVE)

Viveve Medical (NASDAQ:VIVE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018MizuhoReiterated RatingBuyHighView Rating Details
1/4/2018Ladenburg Thalmann Financial ServicesReiterated RatingBuyLowView Rating Details
1/5/2018Northland SecuritiesInitiated CoverageOutperform -> Outperform$8.00LowView Rating Details
10/23/2017CowenSet Price TargetBuy$11.00N/AView Rating Details
8/11/2017Maxim GroupReiterated RatingBuy$11.00HighView Rating Details
5/25/2017Raymond James FinancialInitiated CoverageOutperform -> Outperform$10.00MediumView Rating Details
5/17/2017B. RileyReiterated RatingBuy$10.00MediumView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Viveve Medical (NASDAQ:VIVE) Earnings History and Estimates Chart

Earnings by Quarter for Viveve Medical (NASDAQ:VIVE)

Viveve Medical (NASDAQ VIVE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($0.42)($0.50)$4.10 million$4.07 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.33)($0.54)$3.24 million$3.08 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.51)($0.57)$2.70 million$3.04 millionViewN/AView Earnings Details
2/16/2017Q4 2016($0.48)($0.55)$2.10 million$2.45 millionViewN/AView Earnings Details
11/10/2016Q316($0.48)($0.46)$1.70 million$1.85 millionViewN/AView Earnings Details
8/11/2016Q216($0.48)($0.66)$1.33 million$1.56 millionViewListenView Earnings Details
5/13/2016Q1 2016($0.43)($0.55)$1.29 million$1.28 millionViewN/AView Earnings Details
3/24/2016Q4 2015($0.48)($0.56)$0.75 million$0.75 millionViewN/AView Earnings Details
11/13/2015Q3 2015($0.48)($0.72)$0.58 million$0.58 millionViewN/AView Earnings Details
8/14/2015Q2 2015($0.64)$0.16 million$0.07 millionViewN/AView Earnings Details
5/15/2015Q1 2015($0.72)($1.12)$0.03 million$0.04 millionViewN/AView Earnings Details
3/16/2015Q4 2014($1.52)$0.03 millionViewN/AView Earnings Details
11/14/2014Q3 2014($24.00)($4.16)$0.05 million$0.02 millionViewN/AView Earnings Details
5/15/2014Q1 2014($8.00)($8.00)$0.29 million$0.05 millionViewN/AView Earnings Details
3/28/2014Q4 2013($8.00)($8.00)$0.48 million$0.21 millionViewN/AView Earnings Details
11/14/2013Q3 2013($8.00)($8.00)$0.40 million$0.35 millionViewN/AView Earnings Details
8/14/2013Q2 2013($8.00)($8.00)$0.37 millionViewN/AView Earnings Details
5/15/2013Q1 2013($24.00)($24.00)$0.31 million$0.35 millionViewN/AView Earnings Details
3/28/2013Q4 2012($32.00)($32.00)ViewN/AView Earnings Details
11/14/2012Q3 2012($32.00)$80.00ViewN/AView Earnings Details
8/14/2012Q2 2012($40.00)($28.80)ViewN/AView Earnings Details
5/15/2012Q1 2012($32.00)($33.60)ViewN/AView Earnings Details
3/30/2012Q4 2011($24.00)ViewN/AView Earnings Details
11/14/2011Q3 2011($10.40)ViewN/AView Earnings Details
8/12/2011Q2 2011($4.80)ViewN/AView Earnings Details
5/16/2011Q1 2011($128.80)ViewN/AView Earnings Details
3/29/2011Q4 2010$7.20ViewN/AView Earnings Details
8/16/2010Q2 2010($8.00)ViewN/AView Earnings Details
5/14/2010Q1 2010($14.40)ViewN/AView Earnings Details
3/30/2010Q4 2009($16.00)ViewN/AView Earnings Details
11/10/2009Q3 2009($9.60)ViewN/AView Earnings Details
8/10/2009Q2 2009($8.00)ViewN/AView Earnings Details
5/7/2009Q1 2009($9.60)ViewN/AView Earnings Details
3/12/2009Q4 2008($5.60)ViewN/AView Earnings Details
11/13/2008Q3 2008($7.20)ViewN/AView Earnings Details
8/6/2008Q2 2008($17.60)ViewN/AView Earnings Details
5/15/2008Q1 2008($20.00)ViewN/AView Earnings Details
3/5/2008Q4 2007($21.60)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Viveve Medical (NASDAQ:VIVE) Earnings Estimates

2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.39)($0.39)($0.39)
Q2 20181($0.30)($0.30)($0.30)
Q3 20181($0.25)($0.25)($0.25)
Q4 20181($0.23)($0.23)($0.23)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Viveve Medical (NASDAQ:VIVE)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Viveve Medical (NASDAQ VIVE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 35.10%
Institutional Ownership Percentage: 67.70%
Insider Trades by Quarter for Viveve Medical (NASDAQ:VIVE)
Institutional Ownership by Quarter for Viveve Medical (NASDAQ:VIVE)

Viveve Medical (NASDAQ VIVE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/23/2017Scott DurbinCFOBuy5,000$5.25$26,250.0011,568View SEC Filing  
3/17/2017James G AtkinsonDirectorBuy375,000$4.00$1,500,000.0011,525View SEC Filing  
3/17/2017Patricia SchellerCEOBuy12,500$4.00$50,000.0045,164View SEC Filing  
6/17/2016James G. AtkinsonInsiderBuy100,000$5.00$500,000.00View SEC Filing  
6/17/2016Patricia SchellerCEOBuy6,000$5.00$30,000.00View SEC Filing  
6/17/2016Scott DurbinCFOBuy1,500$5.00$7,500.00View SEC Filing  
6/17/2016Stonepine Capital Management,Major ShareholderBuy300,000$5.00$1,500,000.00View SEC Filing  
9/23/20145Am Partners Ii, LlcMajor ShareholderBuy5,215,664$0.53$2,764,301.92View SEC Filing  
9/23/2014Daniel JanneyDirectorBuy1,895,788$0.53$1,004,767.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Viveve Medical (NASDAQ VIVE) News Headlines

Source:
DateHeadline
Empire Analyst Sees 200% Upside To This Womens Health BiotechEmpire Analyst Sees 200% Upside To This Women's Health Biotech
www.benzinga.com - February 23 at 9:28 AM
Viveve to Participate in BTIG Healthcare ConferenceViveve to Participate in BTIG Healthcare Conference
finance.yahoo.com - February 22 at 9:11 AM
Contrasting Viveve Medical (VIVE) & Intuitive Surgical (ISRG)Contrasting Viveve Medical (VIVE) & Intuitive Surgical (ISRG)
www.americanbankingnews.com - February 19 at 12:16 PM
Zacks: Analysts Anticipate Viveve Medical Inc (VIVE) Will Post Quarterly Sales of $5.09 MillionZacks: Analysts Anticipate Viveve Medical Inc (VIVE) Will Post Quarterly Sales of $5.09 Million
www.americanbankingnews.com - February 17 at 2:08 AM
Viveve Medical (VIVE) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowViveve Medical (VIVE) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 16 at 4:43 PM
Viveve Announces Closing of Public Offering of Shares of Common StockViveve Announces Closing of Public Offering of Shares of Common Stock
finance.yahoo.com - February 12 at 3:25 PM
Viveve to Present at Leerink Global Healthcare ConferenceViveve to Present at Leerink Global Healthcare Conference
finance.yahoo.com - February 9 at 3:32 PM
BRIEF-Viveve Announces Pricing Of Public Offering Of SharesBRIEF-Viveve Announces Pricing Of Public Offering Of Shares
www.reuters.com - February 8 at 3:24 PM
Pre-Open Movers 02/08: (TWTR) (INFN) (GRUB) Higher; (IRBT) (GEMP) (IPHI) Lower (more...)Pre-Open Movers 02/08: (TWTR) (INFN) (GRUB) Higher; (IRBT) (GEMP) (IPHI) Lower (more...)
www.streetinsider.com - February 8 at 3:24 PM
VIVE: SUI Indication Could Further Enhance Marketing Message, Drive AdoptionVIVE: SUI Indication Could Further Enhance Marketing Message, Drive Adoption
finance.yahoo.com - February 8 at 3:24 PM
Mizuho Reiterates "Buy" Rating for Viveve Medical (VIVE)Mizuho Reiterates "Buy" Rating for Viveve Medical (VIVE)
www.americanbankingnews.com - February 8 at 11:18 AM
Viveve Announces Proposed Public Offering of Shares of Common StockViveve Announces Proposed Public Offering of Shares of Common Stock
finance.yahoo.com - February 8 at 6:28 AM
Viveve Medical (VIVE) Upgraded to Hold at ValuEngineViveve Medical (VIVE) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - February 4 at 9:02 AM
Viveve Medical (VIVE) Given "Buy" Rating at MizuhoViveve Medical (VIVE) Given "Buy" Rating at Mizuho
www.americanbankingnews.com - February 1 at 1:52 PM
Viveve Announces Expansion of CMRF Technology Platform into Stress Urinary Incontinence MarketViveve Announces Expansion of CMRF Technology Platform into Stress Urinary Incontinence Market
finance.yahoo.com - January 31 at 3:24 PM
$5.09 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter$5.09 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter
www.americanbankingnews.com - January 31 at 1:54 AM
Viveve Medical Inc (VIVE) Receives Average Recommendation of "Buy" from BrokeragesViveve Medical Inc (VIVE) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - January 30 at 9:24 PM
Zacks: Brokerages Expect Viveve Medical Inc (VIVE) Will Post Earnings of -$0.46 Per ShareZacks: Brokerages Expect Viveve Medical Inc (VIVE) Will Post Earnings of -$0.46 Per Share
www.americanbankingnews.com - January 29 at 11:14 PM
Viveve Medical Inc (VIVE) Expected to Announce Quarterly Sales of $5.09 MillionViveve Medical Inc (VIVE) Expected to Announce Quarterly Sales of $5.09 Million
www.americanbankingnews.com - January 16 at 12:40 AM
Zacks: Analysts Anticipate Viveve Medical Inc (VIVE) Will Post Earnings of -$0.46 Per ShareZacks: Analysts Anticipate Viveve Medical Inc (VIVE) Will Post Earnings of -$0.46 Per Share
www.americanbankingnews.com - January 13 at 1:38 AM
Viveve Medical Inc (VIVE) Receives Consensus Recommendation of "Buy" from AnalystsViveve Medical Inc (VIVE) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 5 at 9:32 PM
Viveve Medical (VIVE) Given "Buy" Rating at Ladenburg Thalmann Financial ServicesViveve Medical (VIVE) Given "Buy" Rating at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - January 5 at 4:22 PM
Form 4 VIVEVE MEDICAL, INC. For: Jan 02 Filed by: JANNEY DANIELForm 4 VIVEVE MEDICAL, INC. For: Jan 02 Filed by: JANNEY DANIEL
www.streetinsider.com - January 5 at 4:04 PM
Viveve Medical (VIVE) Now Covered by Analysts at Northland SecuritiesViveve Medical (VIVE) Now Covered by Analysts at Northland Securities
www.americanbankingnews.com - January 5 at 10:54 AM
miRagen Therapeutics (MGEN) Appoints Arlene Morris to Board - StreetInsider.commiRagen Therapeutics (MGEN) Appoints Arlene Morris to Board - StreetInsider.com
www.streetinsider.com - January 5 at 10:40 AM
Form 4 VIVEVE MEDICAL, INC. For: Jan 02 Filed by: JANNEY DANIEL - StreetInsider.comForm 4 VIVEVE MEDICAL, INC. For: Jan 02 Filed by: JANNEY DANIEL - StreetInsider.com
www.streetinsider.com - January 5 at 10:40 AM
VIVE: Q4 2017 Preannouncement, Full-Year 2018 Initial Guidance Largely Inline With Our EstimatesVIVE: Q4 2017 Preannouncement, Full-Year 2018 Initial Guidance Largely Inline With Our Estimates
finance.yahoo.com - January 4 at 4:29 PM
Viveve Medical (VIVE) Offers Prelim. Q4 Results, FY18 Guidance - StreetInsider.comViveve Medical (VIVE) Offers Prelim. Q4 Results, FY18 Guidance - StreetInsider.com
www.streetinsider.com - January 4 at 10:24 AM
Viveve Announces Preliminary 2017 Fourth Quarter and Year-End Financial Results and Provides 2018 Revenue GuidanceViveve Announces Preliminary 2017 Fourth Quarter and Year-End Financial Results and Provides 2018 Revenue Guidance
finance.yahoo.com - January 4 at 10:24 AM
ValuEngine Lowers Viveve Medical (VIVE) to Strong SellValuEngine Lowers Viveve Medical (VIVE) to Strong Sell
www.americanbankingnews.com - January 1 at 12:34 AM
Reviewing Viveve Medical (VIVE) & Hansen Medical (HNSN)Reviewing Viveve Medical (VIVE) & Hansen Medical (HNSN)
www.americanbankingnews.com - December 30 at 7:12 PM
$5.33 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter$5.33 Million in Sales Expected for Viveve Medical Inc (VIVE) This Quarter
www.americanbankingnews.com - December 29 at 5:52 PM
ETFs with exposure to Viveve Medical, Inc. : December 27, 2017ETFs with exposure to Viveve Medical, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 1:01 PM
Viveve Medical Inc (VIVE) Expected to Post Earnings of -$0.46 Per ShareViveve Medical Inc (VIVE) Expected to Post Earnings of -$0.46 Per Share
www.americanbankingnews.com - December 27 at 10:50 AM
Viveve Medical, Inc. :VIVE-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017Viveve Medical, Inc. :VIVE-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 12:00 PM
VIVE: Sub-Analysis Provides Additional Confidence in Eventual Success of VIVEVE IIVIVE: Sub-Analysis Provides Additional Confidence in Eventual Success of VIVEVE II
finance.yahoo.com - December 12 at 4:43 PM
Viveve Medical Named One of North Americas Fastest Growing CompaniesViveve Medical Named One of North America's Fastest Growing Companies
finance.yahoo.com - December 12 at 10:55 AM
Viveve Medical, Inc. (VIVE) Receives Consensus Recommendation of "Buy" from AnalystsViveve Medical, Inc. (VIVE) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 11 at 9:52 PM
$5.33 Million in Sales Expected for Viveve Medical, Inc. (VIVE) This Quarter$5.33 Million in Sales Expected for Viveve Medical, Inc. (VIVE) This Quarter
www.americanbankingnews.com - December 11 at 2:38 AM
 Analysts Anticipate Viveve Medical, Inc. (VIVE) to Post -$0.46 Earnings Per Share Analysts Anticipate Viveve Medical, Inc. (VIVE) to Post -$0.46 Earnings Per Share
www.americanbankingnews.com - December 9 at 11:42 PM
VIVEVE I Trial Sub-Analysis Published in Journal of Womens HealthVIVEVE I Trial Sub-Analysis Published in Journal of Women's Health
finance.yahoo.com - December 5 at 12:13 PM
ValuEngine Downgrades Viveve Medical (VIVE) to Strong SellValuEngine Downgrades Viveve Medical (VIVE) to Strong Sell
www.americanbankingnews.com - December 2 at 12:40 AM
Streetwise Reports Examines Medical Device Firm Who Analysts Say Has Record Quarterly Revenue Growth, 120% YOYStreetwise Reports Examines Medical Device Firm Who Analysts Say Has Record Quarterly Revenue Growth, 120% YOY
finance.yahoo.com - November 30 at 11:06 AM
-$0.46 Earnings Per Share Expected for Viveve Medical, Inc. (VIVE) This Quarter-$0.46 Earnings Per Share Expected for Viveve Medical, Inc. (VIVE) This Quarter
www.americanbankingnews.com - November 21 at 11:26 PM
Viveve Medical (VIVE) Presents At 8th Annual Craig-Hallum Alpha Select Conference - SlideshowViveve Medical (VIVE) Presents At 8th Annual Craig-Hallum Alpha Select Conference - Slideshow
seekingalpha.com - November 18 at 10:04 AM
Viveve Medical, Inc. (VIVE) Receives Consensus Rating of "Buy" from BrokeragesViveve Medical, Inc. (VIVE) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 16 at 9:54 PM
Viveve Medical, Inc. (VIVE) Research Coverage Started at MizuhoViveve Medical, Inc. (VIVE) Research Coverage Started at Mizuho
www.americanbankingnews.com - November 16 at 7:47 PM
ETFs with exposure to Viveve Medical, Inc. : November 10, 2017ETFs with exposure to Viveve Medical, Inc. : November 10, 2017
finance.yahoo.com - November 12 at 1:11 PM
Edited Transcript of VIVE earnings conference call or presentation 8-Nov-17 10:00pm GMTEdited Transcript of VIVE earnings conference call or presentation 8-Nov-17 10:00pm GMT
finance.yahoo.com - November 12 at 1:11 PM
Reviewing Derma Sciences (DSCI) and Viveve Medical (VIVE)Reviewing Derma Sciences (DSCI) and Viveve Medical (VIVE)
www.americanbankingnews.com - November 9 at 11:06 PM

SEC Filings

Viveve Medical (NASDAQ:VIVE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Viveve Medical (NASDAQ:VIVE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Viveve Medical (NASDAQ VIVE) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.